[32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.

Potsaid, M S

[32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma. [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jan 1978 - 98-104 p. digital

Publication Type: Case Reports; Journal Article

0161-5505


Adenocarcinoma--radiotherapy
Aged
Bone Neoplasms--radiotherapy
Etidronic Acid--therapeutic use
Humans
Male
Middle Aged
Neoplasm Metastasis
Phosphorus Radioisotopes--therapeutic use
Prostatic Neoplasms
Radiotherapy Dosage